DDInter1045 DDInter278
Levamlodipine, also known as S-amlodipine, is a pharmacologically active enantiomer of [amlodipine], an antihypertensive medication. Levamlodipine belongs to the dihydropyridine group of calcium channel blockers. This medication was first marketed in Russia and India before being granted FDA approval. The names S-amlodipine and levamlodipine may be used interchangeably as both substances are the same, however. As a racemic mixture, amlodipine contains (R) and (S)-amlodipine isomers, but only (S)-amlodipine as the active moiety possesses therapeutic activity. Levamlodipine was granted FDA approval on 19 December 2019.
Calcium lactate is a salt that consists of two lactate anions for each calcium cation (Ca2+). It is prepared commercially by the neutralization of lactic acid with calcium carbonate or calcium hydroxide. Approved by the FDA as a direct food substance affirmed as generally recognized as safe, calcium lactate is used as a firming agent, flavoring agent, leavening agent, stabilizer, and thickener . Calcium lactate is also found in daily dietary supplements as a source of calcium. It is also available in various hydrate forms, where calcium lactate pentahydrate is the most common.
Levamlodipine {u} may cause a minor interaction that can limit clinical effects when taken with {v} Darolutamide
Levamlodipine {u} may cause a minor interaction that can limit clinical effects when taken with {v} Ticagrelor
Levamlodipine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Tyropanoic acid
Levamlodipine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Aldesleukin
Levamlodipine {u} may lead to a major life threatening interaction when taken with {v} Enzalutamide
Levamlodipine {u} may lead to a major life threatening interaction when taken with {v} Apalutamide
Levamlodipine may cause a minor interaction that can limit clinical effects when taken with Darolutamide
Levamlodipine may cause a minor interaction that can limit clinical effects when taken with Ticagrelor
Levamlodipine may cause a moderate interaction that could exacerbate diseases when taken with Tyropanoic acid
Levamlodipine may cause a moderate interaction that could exacerbate diseases when taken with Aldesleukin
Levamlodipine may lead to a major life threatening interaction when taken with Enzalutamide
Levamlodipine may lead to a major life threatening interaction when taken with Apalutamide